ArticleOpen forum infectious diseases2023
Clinical Features, Treatment, and Outcome of Psittacosis Pneumonia: A Multicenter Study.
Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 34 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 28 citations in OpenAlex.
- Clinical, laboratory, and radiological features of community-acquired pneumonia due toAnnals of medicine · 2026Article
- Chlamydia psittaci Meningitis, Chile, 2023.Emerging infectious diseases · 2026Article
- Computed tomography findings and severity scores in Chlamydia psittaci pneumonia: a retrospective study of 69 cases with clinical correlation.BMC infectious diseases · 2026Article
- Antimicrobial Management of SevereInfection and drug resistance · 2026Review
- Pneumonia with BALF Detection ofInfection and drug resistance · 2026Article
- A case report of spherical pneumonia caused byFrontiers in medicine · 2026Article
- Co-Infection ofInfection and drug resistance · 2026Article
- Clinical Characteristics of 40 Cases ofInfection and drug resistance · 2026Article
- The relationship betweenFrontiers in medicine · 2026Article
- Non-invasive management of severe chlamydia psittaci pneumonia presenting with hypoxemia and diarrhea: a case report.Frontiers in medicine · 2026Article
- A case of psittacosis pneumonia complicated by rhabdomyolysis.World journal of emergency medicine · 2026Article
- Clinical Features and Risk Factors for Severe Disease in 57 Cases ofInfection and drug resistance · 2026Article
- Clinical Features of 186 Cases ofInfection and drug resistance · 2026Article
- Successful azithromycin treatment ofFrontiers in pharmacology · 2026Article
- Article
- Clinical characteristics and risk factors associated with severe community-acquired pneumonia infected byMicrobiology spectrum · 2025Article
- Chlamydia psittaci pneumonia manifested as pulmonary nodules and cavitary lesions: a case report.BMC infectious diseases · 2025Article
- Chlamydia psittacosis infection complicating cerebral infarction: A case report and literature review.Medicine · 2025Review
- Psittacosis pneumonia with the reversed halo sign: a case report and literature review.BMC infectious diseases · 2025Review
- Liver Function Abnormalities in Patients withInfection and drug resistance · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
21 authors at 11 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We aimed to describe psittacosis pneumonia and risk factors for developing severe pneumonia in this multicenter clinical study. Methods: We collected the data of psittacosis pneumonia cases diagnosed with metagenomic next-generation sequencing (mNGS) assay from April 2018 to April 2022 in 15 tertiary hospitals in China. Results: A total of 122 patients were enrolled; 50.0% had a definite history of bird exposure. In 81.2% of cases, onset happened in autumn or winter. The common symptoms were fever (99.2%), cough (63.1%), fatigue (52.5%), shortness of breath (50.0%), chills (37.7%), central nervous system symptoms (36.9%), myalgia (29.5%), and gastrointestinal tract symptoms (15.6%). Laboratory tests showed that >70% of cases had elevated C-reactive protein, procalcitonin, erythrocyte sedimentation rate, D-dimer, lactate dehydrogenase, and aspartate aminotransferase, and >50% had hyponatremia and hypoproteinemia. The most common imaging finding was consolidation (71.3%), and 42.6% of cases met the criteria for severe pneumonia. Age >65 years and male sex were the risk factors for severe pneumonia. The effective proportion of patients treated with tetracyclines was higher than that of fluoroquinolones (66/69 [95.7%] vs 18/58 [31.0%]; Conclusions: Psittacosis pneumonia has a high rate of severe disease. Proven diagnosis could be rapidly confirmed by mNGS. Tetracycline therapy had a rapid effect and a high cure rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.